Skip to main contentEquity ESG
March 18, 2024
Less capex and more focus
![](/static/images/akros.svg)
March 15, 2024
Investing on energy transition
![](/static/images/akros.svg)
March 08, 2024
Growth ahead despite conservative assumptions
![](/static/images/akros.svg)
March 04, 2024
Undemanding valuation for a high-growth company
![](/static/images/akros.svg)
January 11, 2024
Post-integration of Luminex, Diasorin plots new growth pathways
![](/static/images/akros.svg)
December 11, 2023
AWEsomely poised to spark the hydrogen transition
![](/static/images/akros.svg)